Page last updated: 2024-11-11

ropizine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ropizine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9568666
CHEMBL ID2107093
SCHEMBL ID635135
MeSH IDM0048624

Synonyms (33)

Synonym
1-piperazinamine, 4-(diphenylmethyl)-n-((6-methyl-2-pyridinyl)methylene)-
1-(diphenylmethyl)-4-[[(6-methyl-2-pyridyl)methylene]amino]piperazine
1-piperazinamine, 4-(diphenylmethyl)-n-[(6-methyl-2-pyridinyl)methylene]-
sc-13504
nsc300584
nsc-300584
1-diphenylmethyl-4-[(6-methyl-2-pyridyl)methyleneamino]piperazine
3601-19-2
piperazine, 1-(diphenylmethyl)-4-[[(6-methyl-2-pyridyl)methylene]amino]-
sc 13504
ropizine
unii-q5128gw9d4
nsc 300584
q5128gw9d4 ,
ropizinum [inn-latin]
1-(diphenylmethyl)-4-((6-methyl-2-pyridyl)methylenamino)piperazin
piperazine, 1-(diphenylmethyl)-4-(((6-methyl-2-pyridyl)methylene)amino)-
ropizina [inn-spanish]
ropizinum
ropizine [usan:inn]
1-(diphenylmethyl)-4-(((6-methyl-2-pyridyl)methylene)amino)piperazine
ropizina
1-benzyl-4-(6-methyl-2-pyridyl)methylenamino)piperazin
CHEMBL2107093
ropizine [inn]
ropizine [usan]
SCHEMBL635135
DTXSID60189567
n-(4-benzhydryl-1-piperazinyl)-n-[(e)-(6-methyl-2-pyridinyl)methylidene]amine
(e)-n-(4-benzhydrylpiperazin-1-yl)-1-(6-methylpyridin-2-yl)methanimine
HY-123229
CS-0082158
AKOS040747421
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (66.67)18.7374
1990's4 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]